deltatrials
Recruiting PHASE1 INTERVENTIONAL 2-arm NCT06543290

Azithromycin Before Induction

Azithromycin to Prevent Chorioamnionitis in Women Undergoing Induction of Labor, a Randomized Control Trial

Sponsor: Arrowhead Regional Medical Center

Conditions Infections
Interventions Azithromycin Pill Placebo
Updated 2 times since 2024 Last updated: Sep 8, 2025 Started: Aug 7, 2023 Primary completion: Aug 7, 2026 Completion: Aug 7, 2026
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT06543290, this PHASE1 trial focuses on Infections and remains actively recruiting participants. Sponsored by Arrowhead Regional Medical Center, it has been updated 2 times since 2023, reflecting limited change activity. This study is part of the global effort to build evidence for infectious disease interventions.

Status Flow

~Sep 2024 – ~Oct 2025 · 13 months · monthly snapshotRecruiting~Oct 2025 – present · 9 months · monthly snapshotRecruiting

Change History

2 versions recorded

  1. Oct 2025 — Present [monthly]

    Recruiting PHASE1

  2. Sep 2024 — Oct 2025 [monthly]

    Recruiting PHASE1

    First recorded

Aug 2023

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Arrowhead Regional Medical Center
Data source: Arrowhead Regional Medical Center

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations